Survey to Describe Impact of Reflux Disease on Everyday Life in GERD Patients Before and After 4 Weeks Treatment.

AstraZeneca2,091 enrolled

Overview

To describe the change of impact of reflux symptoms on the everyday life perceived by patients before and after 4 weeks treatment by using GERD Impact Scale questionnaire (GIS) by total GERD patient population and by treatment group; and to describe the concordance between patient-reported and physician-reported symptom load.

Study Type

OBSERVATIONAL

Enrollment

2,091

Conditions

Gastroesophageal Reflux Disease

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with GERD diagnosed clinically or by endoscopy and prescribed with medical treatments * Provision of written informed consent Exclusion Criteria: * Patients cannot read and/or understand GIS * Patients with the history or symptoms of peptic ulcer, gastrointestinal cancer, serious or malignant diseases (anorexia, weight loss, anemia, fever …)

Locations (18)

Research Site

Long Xuyen, An Giang, Vietnam

Research Site

Qui Nhon, Binh Dinh, Vietnam

Research Site

Buon Ma Thuot, Dac Lac, Vietnam

Outcomes

Primary Outcomes

Type, frequency and severity of the GERD symptoms

Time frame: 4 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.